Prevalence and impact of fibromyalgia on patients with type 2 diabetes: a large-scale real-world data analysis

Key Points

• Fibromyalgia prevalence negatively impacts health outcomes in patients with type 2 diabetes, highlighting significant healthcare needs.
• Approximately 20% of individuals with type 2 diabetes also report symptoms of fibromyalgia, emphasizing this dual diagnosis.
• Real-world data analysis from numerous healthcare settings assessed the overlapping presence of fibromyalgia and diabetes complications.
• Addressing the combined burden of these conditions is crucial for improving patient management strategies.